The case fatality rate of COVID‐19 during the Delta and the Omicron epidemic phase: A meta‐analysis

Author:

Kim Kisong1,Cho Kyuyeon1,Song Junmin2,Rahmati Masoud3ORCID,Koyanagi Ai45,Lee Seung Won6ORCID,Yon Dong Keon78ORCID,Il Shin Jae9ORCID,Smith Lee10

Affiliation:

1. Yonsei University College of Medicine Seoul Republic of Korea

2. Keimyung University School of Medicine Daegu Republic of Korea

3. Department of Physical Education and Sport Sciences, Faculty of Literature and Human Sciences Lorestan University Khorramabad Iran

4. Parc Sanitari Sant Joan de Deu/CIBERSAM, ISCIII, Universitat de Barcelona, Fundacio Sant Joan de Deu Sant Boi de Llobregat Barcelona Spain

5. ICREA (Catalan Institution for Research and Advanced Studies) Barcelona Spain

6. Department of Precision Medicine Sungkyunkwan University School of Medicine Suwon Republic of Korea

7. Center for Digital Health, Medical Science Research Institute Kyung Hee University College of Medicine Seoul Republic of Korea

8. Department of Pediatrics, Kyung Hee University Medical Center Kyung Hee University College of Medicine Seoul Republic of Korea

9. Department of Pediatrics Yonsei University College of Medicine Seoul Republic of Korea

10. Centre for Health, Performance, and Wellbeing Anglia Ruskin University Cambridge UK

Abstract

AbstractAs coronavirus variants are constantly occurring, we tried to understand more about the omicron and delta variants that have hit the world. We provided dynamic information on the case fatality rate (CFR) of the Omicron variant over time and to compare it with that of the Delta variant through meta‐analysis. Twenty‐four countries were selected by submission counts, submission dates, and confirmed cases. We defined the Delta or the Omicron epidemic period for individual countries as when each variant is over 90%. We further analyzed the Omicron period by dividing it into the initial plateau, increasing, and decreasing phases according to the number of newly confirmed daily cases. Finally, the meta‐analysis examined the summary and between‐study heterogeneity. The CFR of COVID‐19 during the Omicron epidemic was lower than that during the Delta epidemic (odds ratio [OR]: 0.252, 95% confidence interval [CI] 0.205−0.309). The CFR of COVID‐19 during the initial plateau phase of Omicron was higher than during other phases. (OR: 1.962, 95% CI 1.607−2.397). The CFR of COVID‐19 during the increasing phase was lower than during the decreasing phases (OR: 0.412, 95% CI 0.342–0.498). The Omicron variant had lower CFR compared to the Delta variant, and the initial plateau phase had higher CFR compared to the noninitial phases. These results can help establish global health policies for COVID‐19 in the future.

Publisher

Wiley

Subject

Infectious Diseases,Virology

Reference21 articles.

1. WHO Coronavirus (COVID‐19) Dashboard. WHO Coronavirus (COVID‐19) Dashboard With Vaccination Data. Accessed March 2 2022.https://covid19.who.int/

2. World Health Organization (WHO).Tracking SARS‐CoV‐2 variants.Published n.d.Accessed March 2 2022.https://www.who.int/en/activities/tracking-SARS-CoV-2-variants/

3. The benefits, costs and feasibility of a low incidence COVID-19 strategy

4. A look into the future of the COVID-19 pandemic in Europe: an expert consultation

5. Household transmission of COVID-19 cases associated with SARS-CoV-2 delta variant (B.1.617.2): national case-control study

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3